307 related articles for article (PubMed ID: 12015408)
1. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
Gupta AK
J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Gupta AK
Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
[TBL] [Abstract][Full Text] [Related]
5. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model.
Marchetti A; Piech CT; McGhan WF; Neugut AI; Smith BT
Clin Ther; 1996; 18(4):757-77; discussion 702. PubMed ID: 8879902
[TBL] [Abstract][Full Text] [Related]
7. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Angello JT; Voytovich RM; Jan SA
Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
Jansen R; Redekop WK; Rutten FF
Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
Gupta AK; Lambert J
Int J Dermatol; 1999 Sep; 38 Suppl 2():53-64. PubMed ID: 10515529
[No Abstract] [Full Text] [Related]
10. Terbinafine: a review of its use in onychomycosis in adults.
Darkes MJ; Scott LJ; Goa KL
Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
[TBL] [Abstract][Full Text] [Related]
11. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.
Jaiswal A; Sharma RP; Garg AP
Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857
[TBL] [Abstract][Full Text] [Related]
12. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group.
Arikian SR; Einarson TR; Kobelt-Nguyen G; Schubert F
Br J Dermatol; 1994 Apr; 130 Suppl 43():35-44. PubMed ID: 8186141
[TBL] [Abstract][Full Text] [Related]
13. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
14. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
Gupta AK; Fleckman P; Baran R
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
16. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials.
Bootman JL
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S69-72. PubMed ID: 9594941
[TBL] [Abstract][Full Text] [Related]
18. Treatment costs of three nail lacquers used in onychomycosis.
Marty JP; Lambert J; Jäckel A; Adjadj L
J Dermatolog Treat; 2005; 16(5-6):299-307. PubMed ID: 16428149
[TBL] [Abstract][Full Text] [Related]
19. Oral treatment options for onychomycosis.
Joseph WS
J Am Podiatr Med Assoc; 1997 Nov; 87(11):520-31. PubMed ID: 9397657
[TBL] [Abstract][Full Text] [Related]
20. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Gupta AK; Ryder JE; Johnson AM
Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
